The National Methadone Conference

Sponsored by
American Association for the Treatment of Opioid Dependence
Washington, D.C. ~ April 13-16, 2003

Washington D.C.


Saturday, April 12, 2003

Pre-Conference Session 

NAMA offers special thanks to Mallinckrodt. We also wish to thank

Haworth Press
, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without
whose support the first Certified Methadone Advocate (CMA) Training Course would
not have been possible. 

A Day of Methadone Advocacy Training
NAMA Moves Methadone Advocacy to a New Level with training and certification.
Includes a Photo Album of the Day and Jo L. Sotheran’s presentation on Working a Conference.
Sponsored by NAMA

Honorary Patient Presentation

Presentation of the 4th Honorary Patient Recognition to Dr. Payte.

Monday, April 14, 2003

What do Counselors Really Need to Know?
Hot Topic Round Table 1:30 – 3 PM
Gary Nessenbaum WAMM
(not available)

Administrative Withdrawal: Ethics, Implementationa, and Alternatives
Hot Topic Round Table 1:30 – 3 PM
Joe Neuberger Delaware NAMA

Organizational Meeting
Board and Chapter Meeting 8 PM

Tuesday, April 15, 2003

Medication Assisted Treatment in Different Practice Settings: Patients’ Perspectives.
Workshop Session 1:30 – 3 PM
Joycelyn Woods (Facilitator), James Connolly, Howard, Lotsof, and Roxanne Baker
Basic Track
(available soon)

A Picture Album of the Conference

Smoozing The Conference

Similar Posts

  • Presidential Notes

    Admin 03/17/2022

    Stan Novick Stigma (STIG-ma): noun {From the Latin for “mark” or “brand”} a scar left by a hot iron a mark of shame or discredit an identifying mark or characteristic, i.e.: a specific diagnostic sign of a disease Everyone touched positively by methadone maintenance treatment is familiar with stigmatization. Patients, family members, friends, staff- we…

  • National Alliance of Methadone Advocates Inc 435 Second Avenue New York, NY 10010      

    Admin 09/21/2021

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Patient Support Community and Education Project Meeting

    Admin 05/03/2022

    Sunday, October 17, 2004 Special Meeting In September 2000, the Center for Substance Abuse Treatment brought together the leading national patient support and education organizations for a 2 day meeting to discuss the escalation of opioid dependency and the stigma associated with its related medication assisted treatments. Through this effort, the Methadone Patient Support and…

  • Comparison Chart of Illicit Heroin Addiction and Stabilized Methadone Maintenance

    Admin 04/25/2022

    This chart was prepared by Herman Joseph and Joycelyn Sue Woods and is reprinted from METHADONE TREATMENT WORKS: A COMPENDIUM FOR METHADONE MAINTENANCE TREATMENT Topic Illicit Heroin Addiction Stabilized Methadone Maintenance Onset of action Immediate 30 minutes Duration of action 4 – 6 hours 24 – 36 hours or half-life Route of administration Injection, snorting,…